CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 943 shares (grant or award)
- 4 Grant or award Director acquired 1,568 shares (grant or award)
- 4 Grant or award Director acquired 768 shares (grant or award)
- 4 Grant or award Director acquired 1,294 shares (grant or award)
- 4 Grant or award Director acquired 768 shares (grant or award)
- 4 Grant or award Director acquired 1,195 shares (grant or award)
- 8-K Event Executive or director change · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Option exercise Director acquired 10,000 shares (option exercise)
- 4 Open-market sale Director sold 20,000 shares at an average $9.06 ($181,257)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
Page 53 of 74 · 1,465 filings